Works matching DE "VEDOLIZUMAB"

Results: 392

Comparative Analysis of the 3-Year Persistence Rate with Second-Line Vedolizumab and Tumor Necrosis Factor-α Inhibitors in Patients with Inflammatory Bowel Disease Followed in Gastroenterology Practices in Germany.

Published in:

Digestive Diseases, 2020, v. 38, n. 6, p. 466, doi. 10.1159/000506121

By:

Helwig, Ulf;
Braegger, Fiona;
Kostev, Karel;
Schmidt, Carsten

Publication type:

Article

Real-World Outcomes of Vedolizumab Therapy in Ulcerative Colitis and Crohn's Disease at a Tertiary Referral Center.

Published in:

Digestive Diseases, 2018, v. 37, n. 1, p. 33, doi. 10.1159/000492322

By:

Hoffmann, Peter;
Krisam, Johannes;
Stremmel, Wolfgang;
Gauss, Annika

Publication type:

Article

Emergency colectomy for massive rectal bleeding in a patient with well-controlled ulcerative colitis receiving Vedolizumab.

Published in:

2023

By:

Ciortescu, Irina;
Nemteanu, Roxana;
Gheorghe, Liliana;
Hincu, Corina;
Fortu, Liliana;
Chiriac, Oreste;
Clim, Andreea;
Plesa, Alina

Publication type:

Case Study

COVID-19 Vaccine Booster Dose Willingness among Patients with Inflammatory Bowel Disease on Infliximab and Vedolizumab: A Cross-Sectional Study.

Published in:

Vaccines, 2022, v. 10, n. 8, p. 1166, doi. 10.3390/vaccines10081166

By:

Shehab, Mohammad;
Alrashed, Fatema;
Alfadhli, Ahmad

Publication type:

Article

Role of integrin expression in the prediction of response to vedolizumab: A prospective real‐life multicentre cohort study.

Published in:

Clinical & Translational Medicine, 2022, v. 12, n. 4, p. 1, doi. 10.1002/ctm2.769

By:

De Galan, Cara;
Gonzales, Gerard Bryan;
Van Welden, Sophie;
Tavernier, Simon Jan;
Lobaton, Triana;
Van Moerkercke, Wouter;
Strubbe, Beatrijs;
Peeters, Harald;
Macken, Elisabeth;
De Vos, Martine;
Laukens, Debby;
Hindryckx, Pieter

Publication type:

Article

Case report: Induction and maintenance of steroid-free remission with vedolizumab in a case of steroid-dependent autoimmune pancreatitis.

Published in:

Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1201363

By:

Griebel, Paul;
Tran, Florian;
Luehring, Janina;
Schreiber, Stefan

Publication type:

Article

Successful treatment of a refractory intestinal Behcet's disease with an oncology history by Vedolizumab: a case report and literature review.

Published in:

Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1205046

By:

Ruixia Li;
Xiaofei Li;
He Zhou;
Yanting Shi;
Fang Wang;
Tong Wu;
Jie Liang

Publication type:

Article

Vedolizumab for acute gastrointestinal graft-versushost disease: A systematic review and meta-analysis.

Published in:

Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.1025350

By:

Cheng-Wei Li, Allen;
Chen Dong;
Soon-Tzeh Tay;
Ananthakrishnan, Ashwin;
Sheng-Kai Ma, Kevin

Publication type:

Article

A broad cuproptosis landscape in inflammatory bowel disease.

Published in:

Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.1031539

By:

Yuan Chen;
Xinfang Li;
Ran Sun;
Jiamin Ji;
Fan Yang;
Weiliang Tian;
Wu Ji;
Qian Huang

Publication type:

Article

Exposure–efficacy relationship of vedolizumab subcutaneous and intravenous formulations in Crohn's disease and ulcerative colitis.

Published in:

Expert Review of Clinical Pharmacology, 2024, v. 17, n. 4, p. 403, doi. 10.1080/17512433.2024.2318465

By:

D'Haens, Geert;
Rosario, Maria;
Polhamus, Daniel;
Dirks, Nathanael L.;
Chen, Chunlin;
Kisfalvi, Krisztina;
Agboton, Christian;
Vermeire, Séverine;
Feagan, Brian G.;
Sandborn, William J.

Publication type:

Article

Confocal laser endomicroscopy as predictive biomarker of clinical and endoscopic efficacy of vedolizumab in ulcerative colitis: The DETECT study.

Published in:

PLoS ONE, 2024, v. 19, n. 4, p. 1, doi. 10.1371/journal.pone.0298313

By:

Quénéhervé, Lucille;
Trang-Poisson, Caroline;
Fantou, Aurélie;
Flamant, Mathurin;
Durand, Tony;
Bouguen, Guillaume;
Bregeon, Jérémy;
Oullier, Thibauld;
Amil, Morgane;
Dewitte, Marie;
Bardot, Stéphanie;
Blandin, Stéphanie;
Braudeau, Cécile;
Vibet, Marie-Anne;
Josien, Régis;
Neunlist, Michel;
Bourreille, Arnaud

Publication type:

Article

An indirect comparison of efficacy including histologic assessment and safety in biologic therapy in ulcerative colitis: Systemic review and network meta-analysis.

Published in:

PLoS ONE, 2023, v. 18, n. 11, p. 1, doi. 10.1371/journal.pone.0293655

By:

Chae, Kyungsun;
Seo, Yeon Sook;
Yu, Yun Mi;
Chang, Min Jung;
Choi, Junjeong

Publication type:

Article

Fecal calprotectin is an early predictor of endoscopic response and histologic remission after the start of vedolizumab in inflammatory bowel disease.

Published in:

Therapeutic Advances in Gastroenterology, 2020, v. 13, p. 1, doi. 10.1177/1756284820979765

By:

Pauwels, Renske W. M.;
van der Woude, Christien J.;
Erler, Nicole S.;
de Vries, Annemarie C.

Publication type:

Article

Infliximab, adalimumab, golimumab, vedolizumab and tofacitinib in moderate to severe ulcerative colitis: comparative cost-effectiveness study in Poland.

Published in:

Therapeutic Advances in Gastroenterology, 2020, v. 13, p. 1, doi. 10.1177/1756284820941179

By:

Petryszyn, Pawel;
Ekk-Cierniakowski, Pawel;
Zurakowski, Grzegorz

Publication type:

Article

Good efficacy and safety of vedolizumab in Crohn's disease and ulcerative colitis in a real-world scenario.

Published in:

Therapeutic Advances in Gastroenterology, 2020, v. 13, p. 1, doi. 10.1177/1756284820936536

By:

Zingone, Fabiana;
Barberio, Brigida;
Compostella, Federico;
Girardin, Giulia;
D'Incà, Renata;
Marinelli, Carla;
Marsilio, Ilaria;
Lorenzon, Greta;
Savarino, Edoardo Vincenzo

Publication type:

Article

Could small molecules be used in combination with biologics for inflammatory bowel disease?

Published in:

Expert Review of Clinical Immunology, 2022, v. 18, n. 10, p. 991, doi. 10.1080/1744666X.2022.2104713

By:

D'Amico, Ferdinando;
Danese, Silvio;
Fiorino, Gionata

Publication type:

Article

Differences in Whole-Blood Transcriptional Profiles in Inflammatory Bowel Disease Patients Responding to Vedolizumab Compared with Non-Responders †.

Published in:

International Journal of Molecular Sciences, 2023, v. 24, n. 6, p. 5820, doi. 10.3390/ijms24065820

By:

Haglund, Sofie;
Söderman, Jan;
Almer, Sven

Publication type:

Article

Article Systemic Chemokine Levels with "Gut-Specific" Vedolizumab in Patients with Inflammatory Bowel Disease--A Pilot Study.

Published in:

International Journal of Molecular Sciences, 2017, v. 18, n. 8, p. 1827, doi. 10.3390/ijms18081827

By:

Zwicker, Stephanie;
Lira-Junior, Ronaldo;
Höög, Charlotte;
Almer, Sven;
Bostr Boström, Elisabeth A.

Publication type:

Article

Vedolizumab.

Published in:: Australian Prescriber, 2015, v. 38, n. 6, p. 224
Publication type:: Article

Biosimilars in inflammatory bowel disease.

Published in:

2016

By:

Moore, Gregory T.

Publication type:

journal article

Vedolizumab treatment for immune checkpoint inhibitor-induced enterocolitis.

Published in:

Cancer Immunology, Immunotherapy, 2017, v. 66, n. 5, p. 581, doi. 10.1007/s00262-017-1962-6

By:

Bergqvist, Viktoria;
Hertervig, Erik;
Gedeon, Peter;
Kopljar, Marija;
Griph, Håkan;
Kinhult, Sara;
Carneiro, Ana;
Marsal, Jan

Publication type:

Article

Vedolizumab: An Emerging Treatment Option for Pediatric Inflammatory Bowel Disease.

Published in:

Journal of Pediatric Pharmacology & Therapeutics, 2021, v. 26, n. 8, p. 795, doi. 10.5863/1551-6776-26.8.795

By:

Shah, Pooja;
McDonald, Danielle

Publication type:

Article

Incidence and Course of Joint Inflammation Associated with Inflammatory Bowel Disease in Patients Undergoing Treatment with Vedolizumab/Ustekinumab: The VEDUSTAR Study.

Published in:

Journal of Clinical Medicine, 2024, v. 13, n. 4, p. 1076, doi. 10.3390/jcm13041076

By:

Gonzalez Diaz, Irene;
Gutierrez Riart, Mariana;
Martin-Arranz, Maria Dolores;
Plasencia Rodriguez, Chamaida;
Suarez Ferrer, Cristina

Publication type:

Article

Safety and Effectiveness of Vedolizumab and Ustekinumab in Elderly Patients with Inflammatory Bowel Disease: A Real-Life Multicentric Cohort Study.

Published in:

Journal of Clinical Medicine, 2024, v. 13, n. 2, p. 365, doi. 10.3390/jcm13020365

By:

Holvoet, Tom;
Truyens, Marie;
De Galan, Cara;
Peeters, Harald;
Gismero, Francisco Mesonero;
Elorza, Ainara;
Torres, Paola;
Vandermeulen, Liv;
Jauregui-Amezaga, Aranzazu;
Ferreiro-Iglesias, Rocio;
Zabana, Yamile;
Reverter, Laia Peries;
Geldof, Jeroen;
Lobatón, Triana

Publication type:

Article

Vedolizumab Is Associated with Longer Drug Sustainability Compared to Infliximab in Moderate-to-Severe Ulcerative Colitis: Long-Term Real-World Cohort Data.

Published in:

Journal of Clinical Medicine, 2023, v. 12, n. 13, p. 4488, doi. 10.3390/jcm12134488

By:

Konikoff, Tom;
Yanai, Henit;
Libchik, Dror;
Avni-Biron, Irit;
Snir, Yifat;
Banai, Hagar;
Broytman, Yelena;
Dotan, Iris;
Ollech, Jacob E.

Publication type:

Article

Vedolizumab plus basiliximab as second-line therapy for steroid-refractory lower gastrointestinal acute graft-versus-host disease.

Published in:

Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1408211

By:

Zicheng Gao;
Zhiping Fan;
Zhi Liu;
Xu Ye;
Yunxin Zeng;
Li Xuan;
Fen Huang;
Ren Lin;
Jing Sun;
Qifa Liu;
Na Xu

Publication type:

Article

Vedolizumab‐induced acne in inflammatory bowel disease.

Published in:

2018

By:

Gilhooley, Eimear;
Doherty, Glen;
Lally, Aoife

Publication type:

Case Study

Acute Chest Pain as an Infusion Reaction to Vedolizumab.

Published in:

2022

By:

Levartovsky, Asaf;
Yavzori, Miri;
Fudim, Ella;
Kopylov, Uri;
Ben-Horin, Shomron;
Ungar, Bella

Publication type:

Case Study

Oxytocin signalling in dendritic cells regulates immune tolerance in the intestine and alleviates DSS-induced colitis.

Published in:

Clinical Science, 2021, v. 135, n. 4, p. 597, doi. 10.1042/CS20201438

By:

Dandan Dou;
Jinghui Liang;
Xiangyu Zhai;
Guosheng Li;
Hongjuan Wang;
Liying Han;
Lin Lin;
Yifei Ren;
Shilian Liu;
Chuanyong Liu;
Wei Guo;
Jingxin Li

Publication type:

Article

Vedolizumab trough level monitoring in inflammatory bowel disease: a state-of-the-art overview.

Published in:

2019

By:

Pouillon, Lieven;
Vermeire, Séverine;
Bossuyt, Peter

Publication type:

journal article

Clinical experiences and predictors of success of treatment with vedolizumab in IBD patients: a cohort study.

Published in:

2021

By:

Mühl, Laura;
Becker, Emily;
Müller, Tanja M.;
Atreya, Raja;
Atreya, Imke;
Neurath, Markus F.;
Zundler, Sebastian

Publication type:

journal article

Baseline levels of dynamic CD4<sup>+</sup> T cell adhesion to MAdCAM-1 correlate with clinical response to vedolizumab treatment in ulcerative colitis: a cohort study.

Published in:

2020

By:

Allner, Clarissa;
Melde, Michaela;
Becker, Emily;
Fuchs, Friederike;
Mühl, Laura;
Klenske, Entcho;
Müller, Lisa;
Morgenstern, Nadine;
Fietkau, Konstantin;
Hirschmann, Simon;
Atreya, Raja;
Atreya, Imke;
Neurath, Markus F.;
Zundler, Sebastian

Publication type:

journal article

Vedolizumab in the treatment of Crohn's disease: A promising therapeutic approach.

Published in:

Drug Development Research, 2024, v. 85, n. 4, p. 1, doi. 10.1002/ddr.22220

By:

Zargar, Abrar Ahmad

Publication type:

Article

Successful treatment of chronic refractory pouchitis with vedolizumab.

Published in:

2017

By:

Mir, Fazia;
Yousef, Mohamad;
Partyka, Edward;
Tahan, Veysel

Publication type:

Letter

Factors influencing the discontinuation of biologic therapies in patients with ulcerative colitis.

Published in:

Journal of Pharmaceutical Health Care & Sciences, 2024, v. 10, n. 1, p. 1, doi. 10.1186/s40780-024-00386-2

By:

Fukuyama, Arisa;
Nakashima, Akio;
Miyazaki, Motoyasu;
Fujiki, Masakatsu;
Kakimoto, Hideki;
Hisabe, Takashi;
Imakyure, Osamu

Publication type:

Article

Co-Administration of Proton Pump Inhibitors May Negatively Affect the Outcome in Inflammatory Bowel Disease Treated with Vedolizumab.

Published in:

Biomedicines, 2024, v. 12, n. 1, p. 158, doi. 10.3390/biomedicines12010158

By:

Szemes, Kata;
Farkas, Nelli;
Sipos, Zoltan;
Bor, Renata;
Fabian, Anna;
Szepes, Zoltan;
Farkas, Klaudia;
Molnar, Tamas;
Schafer, Eszter;
Szamosi, Tamas;
Salamon, Agnes;
Vincze, Aron;
Sarlos, Patricia

Publication type:

Article

Do Vedolizumab trough Levels Predict the Outcome of Subsequent Therapy in Inflammatory Bowel Disease?

Published in:

Biomedicines, 2023, v. 11, n. 6, p. 1553, doi. 10.3390/biomedicines11061553

By:

Levartovsky, Asaf;
Cohen, Ido;
Abitbol, Chaya Mushka;
Yavzori, Miri;
Fudim, Ella;
Picard, Orit;
Kopylov, Uri;
Ben-Horin, Shomron;
Ungar, Bella

Publication type:

Article

Exploring the Pipeline of Novel Therapies for Inflammatory Bowel Disease; State of the Art Review.

Published in:

Biomedicines, 2023, v. 11, n. 3, p. 747, doi. 10.3390/biomedicines11030747

By:

Zurba, Yasmin;
Gros, Beatriz;
Shehab, Mohammad

Publication type:

Article

Early Clinical Remission Is a Predictor of Long-Term Remission with the Use of Vedolizumab for Ulcerative Colitis.

Published in:

Biomedicines, 2022, v. 10, n. 10, p. N.PAG, doi. 10.3390/biomedicines10102526

By:

Haga, Keiichi;
Shibuya, Tomoyoshi;
Osada, Taro;
Sato, Shunsuke;
Fukuo, Yuka;
Kobayashi, Osamu;
Yamada, Toshio;
Asaoka, Daisuke;
Ito, Kentaro;
Nomura, Kei;
Haraikawa, Mayuko;
Nomura, Osamu;
Fukushima, Hirofumi;
Murakami, Takashi;
Ishikawa, Dai;
Hojo, Mariko;
Nagahara, Akihito

Publication type:

Article

Plumericin Protects against Experimental Inflammatory Bowel Disease by Restoring Intestinal Barrier Function and Reducing Apoptosis.

Published in:

Biomedicines, 2021, v. 9, n. 1, p. 67, doi. 10.3390/biomedicines9010067

By:

Rapa, Shara Francesca;
Di Paola, Rosanna;
Cordaro, Marika;
Siracusa, Rosalba;
D'Amico, Ramona;
Fusco, Roberta;
Autore, Giuseppina;
Cuzzocrea, Salvatore;
Stuppner, Hermann;
Marzocco, Stefania

Publication type:

Article

Assessment of Vedolizumab Disease‐Drug‐Drug Interaction Potential in Patients With Inflammatory Bowel Diseases.

Published in:

Clinical Pharmacology in Drug Development, 2021, v. 10, n. 7, p. 734, doi. 10.1002/cpdd.891

By:

Sun, Wan;
Lirio, Richard A.;
Schneider, Jennifer;
Aubrecht, Jiri;
Kadali, Harisha;
Baratta, Mike;
Gulati, Parul;
Suri, Ajit;
Lin, Tiffany;
Vasudevan, Raghavan;
Rosario, Maria

Publication type:

Article

Effectiveness and safety of vedolizumab for ulcerative colitis: a single-center retrospective real-world study in China.

Published in:

Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1188751

By:

Kaituo Huang;
Jing Liu;
Wenhao Xia;
Chuwen Tian;
Lingya Yao;
Qian Cao;
Haotian Chen

Publication type:

Article

Expression levels of cellular inhibitor of apoptosis proteins and colitogenic cytokines are inversely correlated with the activation of interferon regulatory factor 4.

Published in:

Clinical & Experimental Immunology, 2022, v. 207, n. 3, p. 340, doi. 10.1093/cei/uxac005

By:

Masaki, Sho;
Watanabe, Tomohiro;
Arai, Yasuyuki;
Sekai, Ikue;
Hara, Akane;
Kurimoto, Masayuki;
Otsuka, Yasuo;
Masuta, Yasuhiro;
Yoshikawa, Tomoe;
Takada, Ryutaro;
Kamata, Ken;
Minaga, Kosuke;
Yamashita, Kouhei;
Kudo, Masatoshi

Publication type:

Article

Live-attenuated vaccination in patients with inflammatory bowel disease while continuing or after elective switch to vedolizumab.

Published in:

Intestinal Research, 2024, v. 22, n. 3, p. 378, doi. 10.5217/ir.2023.00203

By:

Shiga, Hisashi;
Nagai, Hiroshi;
Shimoyama, Yusuke;
Naito, Takeo;
Moroi, Rintaro;
Kakuta, Yoichi;
Kinouchi, Yoshitaka;
Masamune, Atsushi

Publication type:

Article

Vedolizumab for perianal fistulizing Crohn's disease: systematic review and meta-analysis.

Published in:

Intestinal Research, 2022, v. 20, n. 2, p. 240, doi. 10.5217/ir.2021.00091

By:

Ayoub, Fares;
Odenwald, Matthew;
Micic, Dejan;
Dalal, Sushila R.;
Pekow, Joel;
Cohen, Russell D.;
Rubin, David T.;
Sakuraba, Atsushi

Publication type:

Article

Incidence comparison of adverse events in patients with inflammatory bowel disease receiving different biologic agents: retrospective long-term evaluation.

Published in:

Intestinal Research, 2022, v. 20, n. 1, p. 114, doi. 10.5217/ir.2021.00037

By:

Barberio, Brigida;
Savarino, Edoardo Vincenzo;
Card, Timothy;
Canova, Cristina;
Baldisser, Francesco;
Gubbiotti, Alessandro;
Massimi, Davide;
Ghisa, Matteo;
Zingone, Fabiana

Publication type:

Article

Vedolizumab does not increase perioperative surgical complications in patients with inflammatory bowel disease, cohort study.

Published in:

Intestinal Research, 2022, v. 20, n. 1, p. 72, doi. 10.5217/ir.2020.00117

By:

Poylin, Vitaliy Y.;
Serrato, Jose Cataneo;
Del Valle, Jonathan Pastrana;
Feuerstein, Joseph D.

Publication type:

Article

Efficacy and safety of a new vedolizumab subcutaneous formulation in Japanese patients with moderately to severely active ulcerative colitis.

Published in:

Intestinal Research, 2021, v. 19, n. 4, p. 448, doi. 10.5217/ir.2020.00026

By:

Taku Kobayashi;
Hiroaki Ito;
Toshifumi Ashida;
Tadashi Yokoyama;
Masakazu Nagahori;
Tomoki Inaba;
Mitsuhiro Shikamura;
Takayoshi Yamaguchi;
Tetsuharu Hori;
Philippe Pinton;
Mamoru Watanabe;
Toshifumi Hibi

Publication type:

Article

Efficacy of biologic therapies for biologic-naïve Japanese patients with moderately to severely active ulcerative colitis: a network meta-analysis.

Published in:

Intestinal Research, 2021, v. 19, n. 1, p. 53, doi. 10.5217/ir.2019.09146

By:

Toshifumi Hibi;
Isao Kamae;
Pinton, Philippe;
Ursos, Lyann;
Ryuichi Iwakiri;
Hather, Greg;
Patel, Haridarshan

Publication type:

Article

Population pharmacokinetics of vedolizumab in Asian and non-Asian patients with ulcerative colitis and Crohn’s disease.

Published in:

Intestinal Research, 2021, v. 19, n. 1, p. 96, doi. 10.5217/ir.2019.09167

By:

Hiroyuki Okamoto;
Dirks, Nathanael L.;
Maria Rosario;
Tetsuharu Hori;
Toshifumi Hibi

Publication type:

Article